期刊
BIOMATERIALS
卷 95, 期 -, 页码 60-73出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2016.04.008
关键词
Tumor priming; Nanomedicine; Metronomic chemotherapy; Tumor vascular normalization; Paclitaxel
资金
- National Basic Research Program of China [2010CB529806]
- National Natural Science Foundation of China [81272569, 81572998]
- Shanghai Municipal Science and Technology Commission [14JC1491900]
- Innovation Program of Shanghai Municipal Education Commission [13ZZ087]
Normalization of the tumor microenvironment is a promising approach to render conventional chemotherapy more effective. Although passively targeted drug nanocarriers have been investigated to this end, actively targeted tumor priming remains to be explored. In this work, we demonstrate an effective tumor priming strategy using metronomic application of nanoparticles actively targeted to tumor neovasculature. F56 peptide-conjugated paclitaxel-loaded nanoparticles (F56-PTX-NP) were formulated from PEGylated polylactide using an oil in water emulsion approach. Metronomic F56-PTX-NP specifically targeted tumor vascular endothelial cells (ECs), pruned vessels with strong antiangiogenic activity and induced thrombospondin-1 (TSP-1) secretion from ECs. The treatment induced tumor vasculature normalization as evidenced by significantly increased coverage of basement membrane and pericytes. The tumor microenvironment was altered with enhanced pO(2), lower interstitial fluid pressure, and enhanced vascular perfusion and doxorubicin delivery. A normalization window of at least 9 days was induced, which was longer than other approaches using antiangiogenic agents. Together, these results show that metronomic, actively-targeted nanomedicine can induce tumor vascular normalization and modulate the tumor microenvironment, opening a window of opportunity for effective combination chemotherapies. (C) 2016 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据